Modulatory Effects of Nicotine on neuroHIV/neuroAIDS
暂无分享,去创建一个
[1] T. Gould,et al. Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats , 2018, Journal of NeuroVirology.
[2] Ming D. Li,et al. HIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats , 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[3] V. Sagar,et al. Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS , 2017, PloS one.
[4] Lei Zhang,et al. Network and Pathway-Based Analyses of Genes Associated with Parkinson’s Disease , 2016, Molecular Neurobiology.
[5] Lei Zhang,et al. Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach , 2017, Alzheimer's Research & Therapy.
[6] Linda Chang,et al. Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals , 2017, Journal of Neuroimmune Pharmacology.
[7] C. Mactutus,et al. Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1 , 2016, Journal of NeuroVirology.
[8] Shengdi Chen,et al. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease , 2016, Progress in Neurobiology.
[9] D. Kazan,et al. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. , 2016 .
[10] Ming D. Li,et al. Interactive Effects of Ethanol and HIV-1 Proteins on Novelty-Seeking Behaviors and Addiction-Related Gene Expression. , 2016, Alcoholism, clinical and experimental research.
[11] R. Steinbrook. HIV/AIDS in 2016 and Beyond. , 2016, Journal of the American Medical Association (JAMA).
[12] D. Klein,et al. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care , 2016, Journal of acquired immune deficiency syndromes.
[13] J. Joseph,et al. HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities. , 2016, Current HIV research.
[14] Reed J. D. Sorensen,et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 , 2016, The lancet. HIV.
[15] Ryung S. Kim,et al. Gender Differences among Smokers Living with HIV , 2016, Journal of the International Association of Providers of AIDS Care.
[16] Ming D. Li,et al. Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats , 2016, Journal of Neuroimmune Pharmacology.
[17] Ming D. Li,et al. Expression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment , 2016, Journal of NeuroVirology.
[18] C. Mactutus,et al. Progression of temporal processing deficits in the HIV-1 transgenic rat , 2016, Scientific Reports.
[19] David J. Volsky,et al. HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment , 2016, Nature Reviews Neurology.
[20] D. Maric,et al. Characterization of neuropathology in the HIV-1 transgenic rat at different ages , 2016, Journal of Neuroimmunology.
[21] D. Feuerbach,et al. Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders , 2016, Cellular and Molecular Life Sciences.
[22] C. Apetrei,et al. Animal Models for HIV Cure Research , 2016, Front. Immunol..
[23] T. Frieden,et al. Applying Public Health Principles to the HIV Epidemic--How Are We Doing? , 2015, The New England journal of medicine.
[24] J. Lasalde-Dominicci,et al. The α7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory response , 2015, Clinical & translational immunology.
[25] H. Brontë-Stewart,et al. Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease , 2015, Neuropsychology Review.
[26] Brian A. King,et al. Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.
[27] Li Yue-chun,et al. Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3 , 2015, Scientific Reports.
[28] Li Yue-chun,et al. Erratum: Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3 , 2015, Scientific Reports.
[29] B. Becher,et al. Innate and adaptive immune responses in the CNS , 2015, The Lancet Neurology.
[30] H. Lane,et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.
[31] M. Vigorito,et al. The HIV-1 transgenic rat model of neuroHIV , 2015, Brain, Behavior, and Immunity.
[32] Ming D. Li,et al. Nicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memories , 2015, Molecular Brain.
[33] J. Lasalde-Dominicci,et al. Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation , 2015, Journal of Neuroimmune Pharmacology.
[34] R. Cohen,et al. HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? , 2015, Alzheimer's Research & Therapy.
[35] J. Skarbinski,et al. Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States , 2015, Annals of Internal Medicine.
[36] W. Banks,et al. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications , 2015, Brain, Behavior, and Immunity.
[37] F. Speizer,et al. Smoking and mortality--beyond established causes. , 2015, The New England journal of medicine.
[38] K. Sliva. Latest animal models for anti-HIV drug discovery , 2015, Expert opinion on drug discovery.
[39] M. Paiardini,et al. Animal models in HIV cure research , 2015, Journal of virus eradication.
[40] S. Abbondanzo,et al. HIV-1 Transgenic Rats Display Alterations in Immunophenotype and Cellular Responses Associated with Aging , 2014, PloS one.
[41] M. Pentella,et al. Laboratory testing for the diagnosis of HIV infection : updated recommendations , 2014 .
[42] M. Weiner,et al. Smoking and increased Alzheimer's disease risk: A review of potential mechanisms , 2014, Alzheimer's & Dementia.
[43] W. Ho,et al. Animal models to study Mycobacterium tuberculosis and HIV co-infection. , 2014, Dong wu xue yan jiu = Zoological research.
[44] C. Garlanda,et al. The interleukin-1 family: back to the future. , 2013, Immunity.
[45] Jeremy Luban,et al. Overcoming current limitations in humanized mouse research. , 2013, The Journal of infectious diseases.
[46] Anil Kumar,et al. Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes , 2013, Expert opinion on drug metabolism & toxicology.
[47] C. Kahler,et al. The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS , 2013, AIDS care.
[48] Ming D. Li,et al. RNA Deep Sequencing Analysis Reveals That Nicotine Restores Impaired Gene Expression by Viral Proteins in the Brains of HIV-1 Transgenic Rats , 2013, PloS one.
[49] Shaolin Wang,et al. Transcriptome Sequencing of Gene Expression in the Brain of the HIV-1 Transgenic Rat , 2013, PloS one.
[50] B. Nordestgaard,et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] Sulie L. Chang,et al. Ethanol Concentration-Dependent Alterations in Gene Expression During Acute Binge Drinking in the HIV-1 Transgenic Rat , 2013, Alcoholism, clinical and experimental research.
[52] S. Horvath,et al. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer’s disease , 2013, BMC Medical Genomics.
[53] C. Mactutus,et al. Neurobehavioral alterations in HIV-1 transgenic rats: Evidence for dopaminergic dysfunction , 2013, Experimental Neurology.
[54] N. Petrosillo,et al. Smoking and HIV: time for a change? , 2013, BMC Medicine.
[55] T. Olsson,et al. Nicotine might have a protective effect in the etiology of multiple sclerosis , 2013, Multiple sclerosis.
[56] R. Akkina,et al. New generation humanized mice for virus research: comparative aspects and future prospects. , 2013, Virology.
[57] Ming D. Li,et al. Identification and Characterization of Poly(I:C)-induced Molecular Responses Attenuated by Nicotine in Mouse Macrophages , 2013, Molecular Pharmacology.
[58] Alejandra Borjabad,et al. Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer’s Disease, and Multiple Sclerosis , 2012, Journal of Neuroimmune Pharmacology.
[59] Ming D. Li,et al. Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells , 2012, Amino Acids.
[60] Anthony S Fauci,et al. Toward an AIDS-free generation. , 2012, JAMA.
[61] R. Speck,et al. Modeling HIV infection and therapies in humanized mice. , 2012, Swiss medical weekly.
[62] M. Quik,et al. Nicotine as a potential neuroprotective agent for Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[63] M. Aksenov,et al. Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. , 2012, Current HIV research.
[64] M. Kaul,et al. Genetic Knockouts Suggest a Critical Role for HIV Co-Receptors in Models of HIV gp120-Induced Brain Injury , 2012, Journal of Neuroimmune Pharmacology.
[65] Sulie L. Chang,et al. Behavioral and Molecular Evidence for a Feedback Interaction Between Morphine and HIV-1 Viral Proteins , 2012, Journal of Neuroimmune Pharmacology.
[66] H. Lando,et al. Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies , 2012, Current HIV/AIDS Reports.
[67] S. Shimohama,et al. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease. , 2012, Current drug targets.
[68] Ulf Andersson,et al. Reflex principles of immunological homeostasis. , 2012, Annual review of immunology.
[69] A. Nath,et al. Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis , 2012, Disease Models & Mechanisms.
[70] Mamoru Ito,et al. Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.
[71] A. Cesario,et al. Nicotine: specific role in angiogenesis, proliferation and apoptosis , 2012, Critical reviews in toxicology.
[72] C. D. Fowler,et al. Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. , 2011, Biochemical pharmacology.
[73] Johnny J. He,et al. HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs* , 2011, The Journal of Biological Chemistry.
[74] J. Otis,et al. Chronic alcohol ingestion exacerbates skeletal muscle myopathy in HIV-1 transgenic rats , 2011, AIDS research and therapy.
[75] D. Kolson,et al. Current understanding of HIV-associated neurocognitive disorders pathogenesis. , 2011, Current opinion in neurology.
[76] A. Gomez,et al. Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats , 2011, Pharmacology Biochemistry and Behavior.
[77] A. Venkatesan,et al. Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease , 2011, Neurobiology of Disease.
[78] B. Ances,et al. Pathogenesis of HIV in the Central Nervous System , 2010, Current HIV/AIDS reports.
[79] Linda Chang,et al. Methamphetamine-Induced Behavioral and Physiological Effects in Adolescent and Adult HIV-1 Transgenic Rats , 2010, Journal of Neuroimmune Pharmacology.
[80] Ming D. Li,et al. Nicotinic Modulation of Innate Immune Pathways Via α7 Nicotinic Acetylcholine Receptor , 2010, Journal of Neuroimmune Pharmacology.
[81] D. Baker,et al. Inflammation in neurodegenerative diseases , 2010, Immunology.
[82] M. Vigorito,et al. The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART , 2010, Journal of Neuroimmunology.
[83] M. Vigorito,et al. Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat , 2009, Journal of NeuroVirology.
[84] M. McCormack,et al. Effect of cigarette smoking on HIV acquisition, progression, and mortality. , 2009, AIDS education and prevention : official publication of the International Society for AIDS Education.
[85] K. Tracey,et al. Cholinergic control of inflammation , 2009, Journal of internal medicine.
[86] K. Tracey. Reflex control of immunity , 2009, Nature Reviews Immunology.
[87] T. Ikezu,et al. The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era , 2009, Journal of Neuroimmune Pharmacology.
[88] F. Shi,et al. Nicotine and inflammatory neurological disorders , 2009, Acta Pharmacologica Sinica.
[89] Linda Chang,et al. Methamphetamine-Induced Behavioral Sensitization Is Enhanced in the HIV-1 Transgenic Rat , 2009, Journal of Neuroimmune Pharmacology.
[90] M. Stämpfli,et al. How cigarette smoke skews immune responses to promote infection, lung disease and cancer , 2009, Nature Reviews Immunology.
[91] Michael Koval,et al. Chronic alcohol ingestion exacerbates lung epithelial barrier dysfunction in HIV‐1 transgenic rats , 2009, Alcoholism, clinical and experimental research.
[92] J. Ingram. Nicotine: does it have a role in the treatment of skin disease? , 2009, Postgraduate Medical Journal.
[93] E. Hirsch,et al. Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.
[94] Shun Shimohama,et al. Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. , 2009, Biological & pharmaceutical bulletin.
[95] F. Shi,et al. Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity1 , 2009, The Journal of Immunology.
[96] N. Benowitz. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. , 2009, Annual review of pharmacology and toxicology.
[97] Athina Markou,et al. Neurobiology of nicotine dependence , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[98] Rajagopal N. Aravalli,et al. Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1 , 2008, Journal of Neuroimmune Pharmacology.
[99] N. Sonenberg,et al. Translational control of the innate immune response through IRF-7 , 2008, Nature.
[100] M. Smith,et al. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. , 2007, CNS & neurological disorders drug targets.
[101] Gary E. Swan,et al. The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain , 2007, Neuropsychology Review.
[102] M. Vigorito,et al. Spatial Learning and Memory in HIV-1 Transgenic Rats , 2007, Journal of Neuroimmune Pharmacology.
[103] O. Selnes,et al. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment , 2006, Journal of NeuroVirology.
[104] M. Kurokawa,et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I‐κB phosphorylation and nuclear factor‐κB transcriptional activity through nicotinic acetylcholine receptor α7 , 2006 .
[105] F. Joseph McClernon,et al. Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial , 2006, Psychopharmacology.
[106] Mardge H. Cohen,et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. , 2006, American journal of public health.
[107] E. Longhi,et al. Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. , 2006, The Journal of pediatrics.
[108] P. Rueda-Orozco,et al. Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats , 2006, Neuroscience Letters.
[109] N. Rothwell,et al. The role of inflammation in CNS injury and disease , 2006, British journal of pharmacology.
[110] Andrea Scozzafava,et al. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. , 2005, Current pharmaceutical design.
[111] J. Virtamo,et al. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension , 2005, BMC Medical Genetics.
[112] K. Tracey,et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.
[113] B. Giunta,et al. Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120 , 2004, Brain Research Bulletin.
[114] M. Reitz,et al. HIV-1 transgenic rats develop T cell abnormalities. , 2004, Virology.
[115] F. Denaro,et al. A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. , 2003, Kidney international.
[116] Yiwen Ruan,et al. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. , 2003, The American journal of pathology.
[117] N. Sacktor,et al. Human immunodeficiency virus-associated dementia: An evolving disease , 2003, Journal of NeuroVirology.
[118] Howard L. Weiner,et al. Inflammation and therapeutic vaccination in CNS diseases , 2002, Nature.
[119] N. Sacktor. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.
[120] A. Nath. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. , 2002, The Journal of infectious diseases.
[121] A. Minagar,et al. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis , 2002, Journal of the Neurological Sciences.
[122] E. Perry,et al. Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) , 2002, Journal of neurochemistry.
[123] P. Riederer,et al. Parkinsonism in HIV dementia , 2002, Journal of Neural Transmission.
[124] M. Sopori,et al. Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.
[125] M. Reitz,et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[126] S. Vijayaraghavan,et al. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[127] Edward D Levin,et al. Cognitive effects of nicotine , 2001, Biological Psychiatry.
[128] Hui-Xin Wang,et al. Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studies , 2000, Behavioural Brain Research.
[129] H. Forman,et al. Molecular Mechanism of Decreased Glutathione Content in Human Immunodeficiency Virus Type 1 Tat-transgenic Mice* , 2000, The Journal of Biological Chemistry.
[130] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[131] D. Overstreet,et al. Antidepressant effects of nicotine in an animal model of depression , 1999, Psychopharmacology.
[132] L. Mucke,et al. Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus , 1998, Neuroscience.
[133] M. Jaakkola,et al. Assessment of exposure to environmental tobacco smoke. , 1997, The European respiratory journal.
[134] Y. Itoyama,et al. [Pathogenesis of HIV-1-associated-neurologic diseases]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.
[135] A. Matthew,et al. Bovine immunodeficiency virus: molecular biology and virus-host interactions , 1994 .
[136] L. Mucke,et al. Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice , 1994, Nature.
[137] M. Rustici,et al. Binding of HIV‐1 gp120 to the nicotinic receptor , 1992, FEBS letters.
[138] R. Purcell,et al. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[139] R. Custer,et al. A severe combined immunodeficiency mutation in the mouse , 1983, Nature.
[140] Brian A. King,et al. Current Cigarette Smoking Among Adults - United States, 2005-2015. , 2016, MMWR. Morbidity and mortality weekly report.
[141] K. Arga,et al. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. , 2016, Omics : a journal of integrative biology.
[142] Ming D. Li,et al. NeuroHIV and use of addictive substances. , 2014, International review of neurobiology.
[143] Sulie L. Chang,et al. Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic rat. , 2013, Alcoholism, clinical and experimental research.
[144] M. Vigorito,et al. Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats. , 2012, International journal of clinical and experimental medicine.
[145] Jun Kawamata,et al. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. , 2011, Journal of Alzheimer's disease : JAD.
[146] O. Selnes,et al. Please Scroll down for Article Journal of Neurovirology Associations of Cigarette Smoking with Viral Immune and Cognitive Function in Human Immunodeficiency Virus-seropositive Women Associations of Cigarette Smoking with Viral Immune and Cognitive Function in Human Immunodeficiency Virus–seropositiv , 2022 .
[147] N. Benowitz. Nicotine addiction. , 2010, The New England journal of medicine.
[148] E. Albuquerque,et al. Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.
[149] M. Picciotto,et al. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. , 2008, Frontiers in bioscience : a journal and virtual library.
[150] M. Kurokawa,et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. , 2006, Clinical and experimental immunology.
[151] Francisco González-Scarano,et al. The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.
[152] F. Krebs,et al. HIV-1-associated central nervous system dysfunction. , 2000, Advances in pharmacology.
[153] K. Nave,et al. Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. , 1995, AIDS research and human retroviruses.
[154] J. Palca. Nicotine addiction , 1988, Nature.